Boswellia serrata extract and NMXCC95 Curcumin longa extract have been shown in cell culture research to provide superior inhibition of the inflammatory response when each was added to ASU/glucosamine/chondroitin sulfate. Alpha-lipoic acid plus ASU has also been noted to provide better inhibition of prostaglandin E2 (PGE2) production in vitro than ASU alone.

”We are proud of our new DASUQUIN ADVANCED formula,” said Dr. Todd Henderson, President and CEO of Nutramax Laboratories Veterinary Sciences, Inc. “While original DASUQUIN is a superb product, we weren’t content to stop there, but continued to look at other ingredients to enhance the formula.”

DASUQUIN ADVANCED is available in chewable tablets in Small to Medium Dog and Large Dog strengths but, different from original DASUQUIN, is packaged in blisters in convenient dispensing cartons. Each dispensing carton contains blistered tablets and dispensing envelopes, and with a total of 640 tablets per package, it is non-internet friendly. Veterinarians can dispense tablets by the week, month, or other desired period of time to meet each client’s needs. Additionally, the dispensing envelopes can be labeled with the clinic name for increased awareness. The packaging provides maximum flexibility to veterinarians and their clients while decreasing the product’s appeal to online pet pharmacies.

For more information, visit dasuquinadvanced.com or call customer service at (888) 886-6442.